Specific pharmacological targeting of GPER offers promising clinical applications [6,7,8]
Targeting the incretin/glucagon system with triagonists An even more advanced step towards the generation of an effective anti-obesity pharmacotherapy is the report of a single peptide capable of simultaneously activating the receptors for glucagon, GLP-1, and GIP by using a highly effective, balanced triagonist structure [25]
PMID: 18 van StaaTLeufkensHAbenhaimLBegaudBZhangBCooperC
And it sounds like someone who is afraid of societal push-back for saying simply Im on a GLP-1. (think about the parallel for depression: would someone say, Im on medication, but just a micro-dose, so its not THAT bad?!) In most cases, what it actually means is: they're taking a low dose
When you apply glutathione directly to the skin in through Glutathione Serum , creams, masks, or lotions, it's called topical glutathione